Compare, Analyse Panacea Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs354344-   
Low Rs138248-   
Sales per share (Unadj.) Rs74.6102.4-  
Earnings per share (Unadj.) Rs6.7-25.8-  
Cash flow per share (Unadj.) Rs15.5-21.4-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs57.280.4-  
Shares outstanding (eoy) m61.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.9 114.0%   
Avg P/E ratio x36.8-11.5 -320.6%  
P/CF ratio (eoy) x15.9-13.9 -114.5%  
Price / Book Value ratio x4.33.7 116.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,06150,026 30.1%   
No. of employees `0002.34.3 53.9%   
Total wages/salary Rs m1,4713,140 46.8%   
Avg. sales/employee Rs Th1,973.64,027.5 49.0%   
Avg. wages/employee Rs Th635.6731.4 86.9%   
Avg. net profit/employee Rs Th176.8-1,014.8 -17.4%   
INCOME DATA
Net Sales Rs m4,56717,290 26.4%  
Other income Rs m45121 37.0%   
Total revenues Rs m4,61217,411 26.5%   
Gross profit Rs m2,030-2,996 -67.7%  
Depreciation Rs m540746 72.4%   
Interest Rs m1,048468 223.8%   
Profit before tax Rs m486-4,090 -11.9%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77256 30.2%   
Profit after tax Rs m409-4,357 -9.4%  
Gross profit margin %44.4-17.3 -256.5%  
Effective tax rate %15.9-6.2 -253.8%   
Net profit margin %9.0-25.2 -35.5%  
BALANCE SHEET DATA
Current assets Rs m2,41512,664 19.1%   
Current liabilities Rs m9,0777,125 127.4%   
Net working cap to sales %-145.932.0 -455.4%  
Current ratio x0.31.8 15.0%  
Inventory Days Days65111 58.7%  
Debtors Days Days71124 57.2%  
Net fixed assets Rs m8,3337,382 112.9%   
Share capital Rs m6180 76.4%   
"Free" reserves Rs m3,4430-   
Net worth Rs m3,50413,571 25.8%   
Long term debt Rs m4614,769 9.7%   
Total assets Rs m13,75525,636 53.7%  
Interest coverage x1.5-7.7 -18.9%   
Debt to equity ratio x0.10.4 37.5%  
Sales to assets ratio x0.30.7 49.2%   
Return on assets %10.6-15.2 -69.9%  
Return on equity %11.7-32.1 -36.4%  
Return on capital %38.7-19.8 -195.4%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Net fx Rs m7360-   
CASH FLOW
From Operations Rs m1,0491,476 71.1%  
From Investments Rs m-54-453 11.8%  
From Financial Activity Rs m-1,0114,328 -23.4%  
Net Cashflow Rs m-205,351 -0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.75 Rs / ZAR

Compare PANACEA BIOTECH With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: UNICHEM LAB  PFIZER  ABBOTT INDIA  STERLING BIOTECH  AJANTA PHARMA  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views On News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PANACEA BIOTECH SHARE PRICE


Mar 5, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

FEATURED VIDEOS

A Time Correction in the Nifty

The Best Stocks in a Volatile Market

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

More Featured Videos

MARKET STATS